DynaCAD Prostate Brochure

Transcription

DynaCAD Prostate Brochure
Welcome to a better way for
YOU and YOUR patient.
Enhance confidence and
productivity with a comprehensive
solution built around you.
DynaCAD for prostate provides a powerful, easy-to-navigate,
multi-vendor MR image analysis system for quick processing and
management of large volumes of data. Studies open ready to read in
custom hanging protocols with all images synchronized for easy, multiparametric review.
Let DynaCAD further enhance your multi-parametric approach by
calculating color overlay maps based on perfusion characteristics ADC
and diffusion values. Don’t have ADC maps, no worries, DynaCAD can
also process ADC, and interpolated high b-value image series. With a
simple menu selection DynaCAD can create these for your review.
Images display in a
user-friendly,customizable
hanging arrangement.
ADC fusion overlays draw
attention to suspicious regions
within the prostate gland
Additional Features Include:
•Image registration for correction of patient motion artifacts
•Single-click volume analysis, lesion statistics and histograms
•Color overlay based on diffusion ADC values
•Auto-search for suspicious regions of interest (ROIs)
•Inter-sequence registration
•Sub-ROI targeting
•Reverse fusion display of UroNav biopsy cores
•Calculated b-value image creation
Reports can be setup to automatically capture pre selected image sequence or curves, measurements
and annotations. Lesions are assessed using the 2nd edition of PIRADS scoring and incorporated
into standardized reports. Finished reports have the option of being printed saved as a PDF or sent as
DICOM images.
Import and display previous
biopsy core locations and results
from UroNav fusion biopsy.
Segmentation tools for gland and
lesion segmentation and volume
estimation
Invivo is leading the way in Prostate care
With a multifaceted approach to Prostate care combining DynaCAD for Prostate advanced
visualization and analysis, UroNav for MR/ultrasound fusion biopsies, DynaTRIM
(Trans-Rectal Interventional MRI) Hardware, DynaLOC for targeted interventional planning
along with Invivo’s selection of interventional instruments.
DynaCAD sets the stage for targeted interventional
procedures by allowing users to mark suspect areas
for biopsy. With DynaCAD’s Sub-ROI feature, users
can mark a specific location within a finding for
biopsy and assign an overall level of suspension.
For more information about DynaCAD for Prostate or
any of the Complete Solution products from Invivo,
please call us at 1-877-Invivo1, or visit our website at
www.invivocorp.com.
Gainesville, FL U.S.A.
T: 877-INVIVO1
T: 407-275-3220
E: info@invivocorp.com
www.invivocorp.com
Europe:
Alex Kypriotis
T: 0044 (0)7867908926
Products, services, and technical specifications are subject to change without notice.
©2015 Invivo Corporation. All Rights Reserved. 580243 Rev 04
Manufactured by: iCAD, Inc. 98 Spit Brook Road,Suite 100 Nashua, NH 03062 USA

Similar documents

Prostate Cancer - Global Drug Forecast and Market Analysis to 2023 for the $8.2 Billion Market

Prostate Cancer - Global Drug Forecast and Market Analysis to 2023 for the $8.2 Billion Market Prostate cancer market was valued at $2.6 billion in 2013 and it is expected to reach $8.3 million, by 2023. It is estimated that the market will grow at a CAGR of 12.4%. This growth will be driven by the label extensions of currently marketed drugs as well as the launch of nine new premium-priced therapies for the treatment of prostate cancer.

More information